RapidAI's platform leverages artificial intelligence to support clinical decision-making in neurovascular emergencies, such as strokes and aneurysms. It integrates advanced imaging analytics with streamlined workflows, allowing physicians to assess and act on critical patient data rapidly. This results in improved patient outcomes by reducing time to treatment and improving diagnostic accuracy. RapidAI's tools are FDA-cleared and designed to optimize the clinical processes in emergency settings.